Search Results - "van de Laar, M. A. F. J."

Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis by Voshaar, M J H, van den Bemt, B J F, van de Laar, M A F J, van Dulmen, A M, Vriezekolk, J E

“…Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthritis (RA) treatment. However, the full benefits of DMARDs are often not…”
Get full text

Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry by Steunebrink, L M M, Versteeg, G A, Vonkeman, H E, Ten Klooster, P M, Kuper, H H, Zijlstra, T R, van Riel, P L C M, van de Laar, M A F J

“…Treat to target (T2T) is widely accepted as the standard of care for patients with rheumatoid arthritis (RA) and has been shown to be more effective than…”
Get full text

Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study by Meek, I. L., Vonkeman, H. E., Kasemier, J., Movig, K. L. L., van de Laar, M. A. F. J.

“…Purpose Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) are often prescribed concurrently in patients with nociceptive pain and…”
Get full text

Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis by Radovits, B J, Kievit, W, Fransen, J, van de Laar, M A F J, Jansen, T L, van Riel, P L C M, Laan, R F J M

“…To investigate the influence of age on the effectiveness and tolerance of antitumour necrosis factor alpha (TNFalpha) therapy in rheumatoid arthritis (RA). 730…”
Get more information

Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life by Zijlstra, T. R., van de Laar, M. A. F. J., Bernelot Moens, H. J., Taal, E., Zakraoui, L., Rasker, J. J.

“…Objectives. To study the effect of a combination of thalassotherapy, exercise and patient education in people with fibromyalgia. Methods. Patients with…”
Get full text

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice by Versteeg, G. A., Steunebrink, L. M. M., Vonkeman, H. E., ten Klooster, P. M., van der Bijl, A. E., van de Laar, M. A. F. J.

“…Patients in real life may differ from those in clinical trials. The aim of this study is to report 5-year outcomes of a continuous treat-to-target (T2T)…”
Get full text

Determinants of Perceived Health Nonimprovement in Early Rheumatoid Arthritis Patients With Favorable Treatment Outcomes by Steunebrink, L. M. M., Oude Voshaar, M. A. H., Taal, E., Vonkeman, H. E., Zijlstra, T. R., Laar, M. A. F. J.

“…Objective To explore the association between achieving favorable clinical outcomes and patients’ perceived change in overall health status after 12 months of…”
Get full text

Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free by Zijlstra, T. R., Braakman-Jansen, L. M. A., Taal, E., Rasker, J. J., van de Laar, M. A. F. J.

“…Objectives. To estimate the cost-effectiveness of an adjuvant treatment course of spa treatment compared with usual care only in patients with fibromyalgia…”
Get full text

Ranking facilitators and barriers of medication adherence by patients with inflammatory arthritis: a maximum difference scaling exercise by Voshaar, M J H, Vriezekolk, J E, van Dulmen, A M, van den Bemt, B J F, van de Laar, M A F J

“…Facilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARDs) have been identified by patients with inflammatory arthritis earlier…”
Get full text

Validation of a Dutch translation of the fibromyalgia impact questionnaire by Zijlstra, T. R., Taal, E., van de Laar, M. A. F. J., Rasker, J. J.

“…Objectives. To validate a Dutch translation of the fibromyalgia impact questionnaire (FIQ). Materials and methods. Data were taken from two randomized clinical…”
Get full text

Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric by Voshaar, M. A. H. Oude, Vonkeman, H. E., Courvoisier, D., Finckh, A., Gossec, L., Leung, Y. Y., Michaud, K., Pinheiro, G., Soriano, E., Wulfraat, N., Zink, A., van de Laar, M. A. F. J.

“…Objectives Outcomes obtained using different physical function patient reported outcome measures (PROMs) are difficult to compare. To facilitate…”
Get full text

Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare by Janssen, C. A., Oude Voshaar, M. A. H., ten Klooster, P. M., Vonkeman, H. E., van de Laar, M. A. F. J.

“…Lowering serum urate levels below the threshold for crystal formation with urate-lowering therapy (ULT) has been associated with a lower risk for gout flare…”
Get full text

A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands by Janssen, C. A., Oude Voshaar, M. A. H., Vonkeman, H. E., Krol, M., van de Laar, M. A. F. J.

“…Urate-lowering therapy (ULT) is a recommended life-long treatment for gout patients. However, despite these recommendations, recurrent gout attacks are…”
Get full text

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout by Reinders, M K, Haagsma, C, Jansen, T L Th A, van Roon, E N, Delsing, J, van de Laar, M A F J, Brouwers, J R B J

“…To compare the efficacy and tolerability of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day used to attain a target serum urate concentration…”
Get more information

Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry by Arts, E E A, Jansen, T L, Den Broeder, A, Vonkeman, H E, Dutmer, E, Van de Laar, M A F J, Van Riel, P L C M, Fransen, J

Get more information

Efficacy of serology driven “test and treat strategy” for eradication of H. pylori in patients with rheumatic disease in the Netherlands by de Leest, H. T. J. I., Steen, K. S. S., Lems, W. F., van de Laar, M. A. F. J., Huisman, A. M., Kadir, S. W., Houben, H. H. M. L., Kostense, P. J., Kuipers, E. J., Dijkmans, B. A. C., Debets-Ossenkopp, Y. J.

“…The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and either clarithromycin or…”
Get full text

Platelet function is inhibited by non‐selective non‐steroidal anti‐inflammatory drugs but not by cyclo‐oxygenase‐2‐selective inhibitors in patients with rheumatoid arthritis by Knijff‐Dutmer, E. A. J., Kalsbeek‐Batenburg, E. M., Koerts, J., van de Laar, M. A. F. J.

“…Background. Interaction with platelet function by non‐steroidal anti‐inflammatory drugs (NSAIDs) is related to the inhibition of cyclo‐oxygenase‐1 (COX‐1). In…”
Get full text

Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation by Van Roon, E. N., Hoekstra, M., Tobi, H., Jansen, T. L. TH. A., Bernelot Moens, H. J., Brouwers, J. R. B. J., Van De Laar, M. A. F. J.

“…Aims To determine factors predictive for leflunomide drug survival in an outpatient population with rheumatoid arthritis in a setting of care‐as‐usual. Methods…”
Get full text

Patient-centred care in established rheumatoid arthritis by Voshaar, M.J.H., MSc, Nota, I., MSc, van de Laar, M.A.F.J., MD, PhD, van den Bemt, B.J.F., PharmD, PhD

“…Abstract Review of the evidence on patient-centred care (PCC) in rheumatoid arthritis (RA) shows that involving the patient as an individual – with unique…”
Get full text

Participation in online patient support groups endorses patients’ empowerment by van Uden-Kraan, C.F, Drossaert, C.H.C, Taal, E, Seydel, E.R, van de Laar, M.A.F.J

“…Abstract Objective Although much has been expected of the empowering effect of taking part in online patient support groups, there is no direct evidence thus…”
Get full text